Advanced search
Publication Cover
Platelets Volume 10, 1999 - Issue 4
Submit an article Journal homepage
45
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Docosahexanoic acid and docosapentanoic acid incorporation into human platelets after 24 and 72 hours: Inhibitory effects on platelet reactivity

L. A. Cheryk, J. A. Conquer, B. J. Holub, P. A. Gentry Department of Biomedical Sciences; Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, ON, Canada N1G 2W1
Pages 203-211 | Published online: 07 Jul 2009

  • Kromhout D, Bosschieter EB, De Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205-9.
  • Kromhout D, Feskens EJM, Bow les CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int J Epidemiol 1995; 24: 340-5.
  • Shekelle R, Missell L, Paul O, MacMillan-Shryock A, Stamler J. Fish consumption and mortality from coronary heart disease (letter). N Engl J Med 1985; 313: 820.
  • Dolecek TA, Grandits G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial. World Rev Nutr Diet 1991; 66: 205-16.
  • Norell SE, Ahlbom A, Fleychting M, Pedersen NL. Fish consumption and mortality from heart disease. Br Med J 1986; 293: 426.
  • Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P, Walsh MK, Morris D, Shekelle RB. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997; 336: 1046-53.
  • Kristensen SD, Schmidt EB, Dyerberg J. Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: A review with particular emphasis on implications for cardiovascular disease. J Int Med 1989; 225: 141-50.
  • Seidelin KN, Myrup B, Fisher-Hansen B. n-3 Fatty acids in adipose tissue and coronary heart disease are inversely related. Am J Clin Nutr 1992; 55: 1117-9.
  • Hodgson JM, Wahlqvist ML, Bonall JA, Balazs, ND. Can linoleic acid contribute to coronary heart disease? Am J Clin Nutr 1993; 58: 228-34.
  • Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi, LH, Cobb LA, Copass MK, Psaty BM, Memeaitre R, Retzlaff B, Childs M, Knopp RH. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J Am Med Assoc 1995; 274: 1363-7.
  • Bonaa KH, Bjerve KS, Nordoy A. Habitual fish consumption, plasma phospholipid fatty acids, and serum lipids: the Tromse Study. Am J Clin Nutr 1992; 55: 1126-34.
  • Harris WS. n-3 Fatty acids and lipoproteins: Comparison of results from human and animal studies. Lipids 1996; 31: 243-52.
  • Malle E, Kostner GM. Effects of fish oils on lipid variables and platelet function indices. Prostagland Leukotr Essent Fatty Acids 1993; 49: 645-63.
  • Herold PM, Kinsella JE. Fish oil consumption and decreased risk of cardiovascular disease: a comparison of findings from animal and human feeding trials. Am J Clin Nutr 1986; 43: 566-98.
  • Semplicini A, Val le R. Fish oils and their possible role in the treatment of cardiovascular diseases. Pharmac Ther 1994; 61: 385-97.
  • Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review. J Lipid Res 1989; 30: 785-807.
  • Wojenski CM, Silver MJ, Walker J. Eicosapentaenoic acid ethyl ester as an antithrombotic agent: Comparison to an extract of fish oil. Biochimica et Biophysics Acta 1991; 1081: 33-8.
  • Gaudette DC, Holub BJ. Docosahexaenoic acid (DHA) and human platelet activity. J Nutr Biochem 1991; 2: 116-21.
  • Holme S, Brox JH, Krane H, Nordoy A. The effect of albumin bound polyunsaturated fatty acids on human platelets. Thromb Haemostas 1984; 51: 32-6.
  • Croset M, Bay on Y, Lagarde M. Incorporation and turnover of eicosapentaenoic and docosahexaenoic acids in human blood platelets in vitro. Biochem J 1992; 281: 309-16.
  • Chardigny J-M, Sébédio J-L, Juanéda P, Vatele J-M, Grandgirard A. Effects of trans n-3 polyunsaturated fatty acids on human platelet aggregation. Nutr Res 1995; 15: 1463-71.
  • Croset M, Lagarde M. In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets: Effect on aggregation. Thromb Haemostas 1986; 56: 57-62.
  • Swann PG, Parent CA, Croset M, Fonlupt P, Lagarde M, Venton DL, Le Breton GC. Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function. J Biochem Chem 1990; 265: 21692-7.
  • Lagarde M, Drouot B, Guichardant M, Dechavanne M. In vitro incorporation and metabolism of some icosaenoic acids in platelets. Effect on arachidonic acid oxygenation. Biochim Biophys Acta 1985; 833: 52-8.
  • Bayon Y, Graset M, Daveloose D, Guerbette F, Chirouze V, Viret J, Kader J-C, Lagarde M. Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors. J Lipid Res 1995; 36: 47-56.
  • Fisher S, Weber PC. Thromboxane A3 (TxA3) is formed in human platelets after dietary eicosapentaenoic acid (20:5w3). Biochem Biophys Res Comm 1983; 116: 1091-9.
  • Fisher S, Weber PC. Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 1984; 307: 165-8.
  • Holme S, Vaidja K, Murphy S. Platelet storage at 22'C: Effect of type of agitation on morphology, viability, and function in vitro. Blood 1978; 52: 425-35.
  • George JN. Changes in platelet membrane glycoproteins during blood bank storage. Blood Cells 1992; 18: 501-11.
  • Rinder HM, Snyder EL. Activation of platelet concentration during preparation and storage. Blood Cells 1992; 18: 445-56.
  • Rinder HM, Snyder EL, Bonan JL, Napychank PA, Malkus H, Smith BR. Activation in stored platelet concentrates: Correlation between membrane expression of P-selectin, glycoprotein IIb-IIa, and ß-thromboglobulin release. Transfusion 1993; 33: 25-9.
  • White JG. Ultrastructural changes in stored platelets. Blood Cells 1992; 18: 461-75.
  • Menitove JE, Frenzke M, Aster RH. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates. Transfusion 1984; 24: 528-31.
  • Menitove JE, Frenzke M, Aster RH. Use of PGE1 for preparation of platelet concentrates. Transfusion 1986; 26: 346-50.
  • Bode AP, Holme S, Heaton WA, Swanson MS. Extended storage of platelets in an artificial medium with the platelet activation inhibitors prostaglandin EI and theophylline. Vox Sang 1991; 60: 105-12.
  • Bode AP, Miller DT. Metabolic status of platelet concentrates during extended storage: improvement with pharmacological inhibitors and reduced surface-to-volume ratio. Vox Sang 1989; 57: 19-24.
  • Hauptmann J, Kaiser B, Markwardt F. Anticoagulant action of synthetic tight binding inhibitors of thrombin in vitro and in vivo. Thromb Res 1985; 39: 771-5.
  • Bode A, Miller DT. The use of thrombin inhibitors and aprotinin in the preservation of platelets stored for transfusion. J Lab Clin Med 1989; 113: 753-8.
  • Menitove JE, Kagen LR, Aster RH. Recovery and survival in vivo of platelet concentrates prepared with prostaglandin E1. Transfusion 1988; 28: 56-8.
  • Bode AP, Miller DT. Preservation of in vitro function of platelets stored in the presence of inhibitors of platelet activation and a specific inhibitor of thrombin. J Lab Clin Med 1988; 111: 118-24.
  • Mrowiec ZR, Oleksowicz L, Zuckerman D, De Leon-Fernandez M, Khorshidi M, Dutcher JP, Puszkin EG. Buffy coat platelets stored in apyrase, aprotinin, and ascorbic acid in a suspended bag: combined strategies for reducing platelet activation during storage. Transfusion 1996; 36: 5-10.
  • Conquer JA, Holub BJ. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J Nutr 1996; 126: 3032-9.
  • Conquer JA, Holub BJ. Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids 1997; 32: 341-5.
  • Gentry PA, De Jong CG, Basrur PK. Stability of bovine platelets stored at ambient temperature. Comp Haemal Int 1992; 2: 213-9.
  • Cheryk LA, Gentry PA, Tablin F. Morphological characteristics of bovine platelets activated with platelet activating factor or thrombin. Comp Haemat Int 1997; 7: 88-94.
  • Grandoni KM, Gentry PA, Holub BJ, Yagen B. Trichothecen mycotoxins inhibit phosphoinositide hydrolysis in bovine platelets stimulated with platelet activating factor. Toxicology 1992; 72: 51-60.
  • Holub BJ, Skeaff CM. Nutritional regulation of cellular phosphatidylinositol. Meth Enzymol 1987; 141: 234-55.
  • Bondy GS, Gentry PA. Characterization of the normal bovine platelet aggregation response. Comp Biochem Physiol 1989; 92C: 67-72.
  • Gentry PA, Cheryk LA, Shanks RD, Healey R. An inherited platelet function defect in a Simmental crossbred herd. Can J Vet Res 1997; 61: 128-33.
  • Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
  • Tablin F, Castro MD. Equine platelets contain an anisotropic array of microtubules which reorganise upon activation. Comp Haematol Int 1992; 2: 125-32.
  • Siess W, Scherer B, Bohlig B, Roth P, Kurzmann I, Weber PC. Platelet membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet, lancet 1980; 1: 441-4.
  • Needleman P, Raz A, Minkes S, Ferendilli JA, Sprecher H. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci USA 1979; 76: 944-8.
  • Hwang DH. Species variation in platelet aggregation. In: Longeneck GL ed. The Platelets: Physiology and Pharmacology. London: Academic Press, 1985: 289-305.
  • Blajchman MA, Lee DH. The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes. Transfusion Med Rev 1997; 11: 95-105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.